Amanote Research

Amanote Research

    RegisterSign In

Is There a Place for Plasma Osteaopontin as Key Mediator in Patients With Diabetic Nephropathy ?

The Egyptian Journal of Hospital Medicine
doi 10.12816/0018759
Full Text
Open PDF
Abstract

Available in full text

Date

October 1, 2015

Authors
Wafaa Mohi El-Deen Abd El-FatahMona Abd El-Raof Abd El-Kader
Publisher

Egypts Presidential Specialized Council for Education and Scientific Research


Related search

Diabetic Nephropathy: Is There a Role for Oxidative Stress?

Free Radical Biology and Medicine
BiochemistryPhysiology
2018English

Is There a Place for Character Education?

SSRN Electronic Journal
2008English

Complement Activation in Patients With Diabetic Nephropathy

Kidney International Reports
Nephrology
2018English

Diabetic Nephropathy: Is It Always There? Assumptions, Weaknesses and Pitfalls in the Diagnosis

Hormones
MedicineEndocrinologyMetabolismDiabetes
2018English

Assessment of Progranulin in Egyptian Type 2 Diabetic Patients as a Novel Biomarker for Diabetic Nephropathy

International Journal of Biosciences (IJB)
2016English

Urinary Smad1 as a New Biomarker for Diabetic Nephropathy in Patients With Type 1 Diabetes Mellitus

Journal of Diabetes & Metabolism
2017English

Screening for Galactosemia: Is There a Place for It?

International Journal of General Medicine
Medicine
2019English

Dihydroergotamine (DHE) – Is There a Place for Its Use?

Journal of Pre-Clinical and Clinical Research
2018English

Is There a Place for Dietary Fiber Supplements in Weight Management?

Current obesity reports
Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy